ondansetron has been researched along with Air Sickness in 16 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective randomized study was performed to assess the value of some individual risk factors for postoperative nausea and vomiting (PONV), and to compare the efficacy of ondansetron, metoclopramide, dexamethason, and combinations of these antiemetics in preventing PONV in patients after laparoscopic cholecystectomy." | 9.12 | Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. ( Leksowski, K; Peryga, P; Szyca, R, 2006) |
| "Ondansetron is currently being explored as a treatment for motion sickness due to its proven prophylactic effect on post-operative nausea, the nausea and vomiting associated with chemotherapy, and its lack of side effects." | 9.12 | High dose ondansetron for reducing motion sickness in highly susceptible subjects. ( Elkins, AN; Muth, ER, 2007) |
| "To determine (1) the efficacy and safety of ondansetron in the prevention of postoperative nausea and vomiting (PONV) in male outpatients; (2) prognostic factors for PONV in male outpatients; and (3) patients' perceptions of the debilitating effects of PONV in the ambulatory surgery setting." | 9.08 | Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group. ( Cox, F; Joslyn, AF; Khalil, SN; Kovac, AL; Pearman, MH; Prillaman, BA; Scuderi, PE, 1996) |
| " This difference was still significant when controlling for age, body weight, history of motion sickness, previous PONV episodes, duration of anesthesia, and intraoperative fentanyl consumption using a logistic model." | 9.08 | Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. ( Finco, G; Gottin, L; Grosso, S; Ischia, S; Mosaner, W; Pinaroli, AM; Polati, E; Verlato, G, 1997) |
| "We studied the efficacy and safety of intravenous ondansetron 4 mg for the prevention of postoperative nausea and vomiting after minor gynaecological laparoscopic surgery in Oriental women." | 9.07 | Ondansetron 4 mg for the prevention of nausea and vomiting after minor laparoscopic gynaecological surgery. ( Chen, PP; Critchley, LA; Gin, TA; Ray, AK; Rowbottom, YM; Suen, TK, 1994) |
| "The post-operative anti-emetic efficacy of 4 and 8 mg of ondansetron in adult patients with and without a previous history of motion sickness (PHMS) was assessed by meta-analysis." | 8.80 | Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. ( Canosa, L; Figueredo, E, 1999) |
| "The meclizine group had lower VNRS scores in the PACU at 15 (P = ." | 6.73 | Meclizine in combination with ondansetron for prevention of postoperative nausea and vomiting in a high-risk population. ( Benfield, DA; Forrester, CM; Kelly, JA; Matern, CE; Pellegrini, JE, 2007) |
| "The exact incidence of postoperative nausea and vomiting (PONV) in patients on steroids undergoing neurosurgical procedures is not known." | 6.73 | Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors. ( Chandrashekharappa, KN; Mukherjee, KK; Nakra, D; Wig, J; Yaddanapudi, LN, 2007) |
| " The antiemetic efficacy of NK1 receptor antagonists against chemotherapy-induced emesis is, however, enhanced when combined with a 5-HT3 receptor antagonist." | 6.69 | Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. ( Clemes, SA; House, F; Palmer, JL; Reid, K; Somal, HS; Stott, JR; Troakes, C; Wright, RJ, 2000) |
| "A prospective randomized study was performed to assess the value of some individual risk factors for postoperative nausea and vomiting (PONV), and to compare the efficacy of ondansetron, metoclopramide, dexamethason, and combinations of these antiemetics in preventing PONV in patients after laparoscopic cholecystectomy." | 5.12 | Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. ( Leksowski, K; Peryga, P; Szyca, R, 2006) |
| "Ondansetron is currently being explored as a treatment for motion sickness due to its proven prophylactic effect on post-operative nausea, the nausea and vomiting associated with chemotherapy, and its lack of side effects." | 5.12 | High dose ondansetron for reducing motion sickness in highly susceptible subjects. ( Elkins, AN; Muth, ER, 2007) |
| "The purpose of this study was to determine the effects of the serotonin (5-HT3) receptor-antagonist antiemetics ondansetron and granisetron on the development of gastric tachyarrhythmia, nausea, and other symptoms of motion sickness." | 5.09 | The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. ( Chillas, JC; Knox, GW; Levine, ME; Stern, RM, 2000) |
| "To determine (1) the efficacy and safety of ondansetron in the prevention of postoperative nausea and vomiting (PONV) in male outpatients; (2) prognostic factors for PONV in male outpatients; and (3) patients' perceptions of the debilitating effects of PONV in the ambulatory surgery setting." | 5.08 | Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group. ( Cox, F; Joslyn, AF; Khalil, SN; Kovac, AL; Pearman, MH; Prillaman, BA; Scuderi, PE, 1996) |
| " This difference was still significant when controlling for age, body weight, history of motion sickness, previous PONV episodes, duration of anesthesia, and intraoperative fentanyl consumption using a logistic model." | 5.08 | Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. ( Finco, G; Gottin, L; Grosso, S; Ischia, S; Mosaner, W; Pinaroli, AM; Polati, E; Verlato, G, 1997) |
| "We studied the efficacy and safety of intravenous ondansetron 4 mg for the prevention of postoperative nausea and vomiting after minor gynaecological laparoscopic surgery in Oriental women." | 5.07 | Ondansetron 4 mg for the prevention of nausea and vomiting after minor laparoscopic gynaecological surgery. ( Chen, PP; Critchley, LA; Gin, TA; Ray, AK; Rowbottom, YM; Suen, TK, 1994) |
| "The post-operative anti-emetic efficacy of 4 and 8 mg of ondansetron in adult patients with and without a previous history of motion sickness (PHMS) was assessed by meta-analysis." | 4.80 | Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. ( Canosa, L; Figueredo, E, 1999) |
| "Seasickness is a common problem, causing a significant decrement in performance among naval crew." | 2.74 | Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea. ( Asna, N; Bar, R; Hershkovitz, D; Kaminski, G; Shupak, A; Tal, D, 2009) |
| "The meclizine group had lower VNRS scores in the PACU at 15 (P = ." | 2.73 | Meclizine in combination with ondansetron for prevention of postoperative nausea and vomiting in a high-risk population. ( Benfield, DA; Forrester, CM; Kelly, JA; Matern, CE; Pellegrini, JE, 2007) |
| "The exact incidence of postoperative nausea and vomiting (PONV) in patients on steroids undergoing neurosurgical procedures is not known." | 2.73 | Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors. ( Chandrashekharappa, KN; Mukherjee, KK; Nakra, D; Wig, J; Yaddanapudi, LN, 2007) |
| " The antiemetic efficacy of NK1 receptor antagonists against chemotherapy-induced emesis is, however, enhanced when combined with a 5-HT3 receptor antagonist." | 2.69 | Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. ( Clemes, SA; House, F; Palmer, JL; Reid, K; Somal, HS; Stott, JR; Troakes, C; Wright, RJ, 2000) |
| "Pretreatment with ondansetron, a serotonin 5-HT3 receptor antagonist, which is used to treat nausea in patients in chemo- or radiation therapy, attenuated hypothermia by ~30%." | 1.40 | Thermoregulatory correlates of nausea in rats and musk shrews. ( Cerri, M; Corrigan, JJ; Del Vecchio, F; Dragic, AS; Kamphee, A; Nalivaiko, E; Ngampramuan, S; Romanovsky, AA; Rudd, JA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ngampramuan, S | 1 |
| Cerri, M | 1 |
| Del Vecchio, F | 1 |
| Corrigan, JJ | 1 |
| Kamphee, A | 1 |
| Dragic, AS | 1 |
| Rudd, JA | 1 |
| Romanovsky, AA | 1 |
| Nalivaiko, E | 1 |
| Banting, J | 1 |
| Meriano, T | 1 |
| Hershkovitz, D | 1 |
| Asna, N | 1 |
| Shupak, A | 1 |
| Kaminski, G | 1 |
| Bar, R | 1 |
| Tal, D | 1 |
| Sutton, M | 1 |
| Mounsey, AL | 1 |
| Russell, RG | 1 |
| Leksowski, K | 1 |
| Peryga, P | 1 |
| Szyca, R | 1 |
| Forrester, CM | 1 |
| Benfield, DA | 1 |
| Matern, CE | 1 |
| Kelly, JA | 1 |
| Pellegrini, JE | 1 |
| Muth, ER | 1 |
| Elkins, AN | 1 |
| Wig, J | 1 |
| Chandrashekharappa, KN | 1 |
| Yaddanapudi, LN | 1 |
| Nakra, D | 1 |
| Mukherjee, KK | 1 |
| Suen, TK | 1 |
| Gin, TA | 1 |
| Chen, PP | 1 |
| Rowbottom, YM | 1 |
| Critchley, LA | 1 |
| Ray, AK | 1 |
| Kovac, AL | 1 |
| Pearman, MH | 1 |
| Khalil, SN | 1 |
| Scuderi, PE | 1 |
| Joslyn, AF | 1 |
| Prillaman, BA | 1 |
| Cox, F | 1 |
| Polati, E | 1 |
| Verlato, G | 1 |
| Finco, G | 1 |
| Mosaner, W | 1 |
| Grosso, S | 1 |
| Gottin, L | 1 |
| Pinaroli, AM | 1 |
| Ischia, S | 1 |
| Benline, TA | 1 |
| French, J | 1 |
| Poole, E | 1 |
| Figueredo, E | 1 |
| Canosa, L | 1 |
| Reid, K | 1 |
| Palmer, JL | 1 |
| Wright, RJ | 2 |
| Clemes, SA | 1 |
| Troakes, C | 1 |
| Somal, HS | 1 |
| House, F | 1 |
| Stott, JR | 2 |
| Levine, ME | 1 |
| Chillas, JC | 1 |
| Stern, RM | 1 |
| Knox, GW | 1 |
| Barnes, GR | 1 |
| Ruddock, CJ | 1 |
3 reviews available for ondansetron and Air Sickness
| Article | Year |
|---|---|
Sea State Green.
Topics: Acupressure; Antiemetics; Cholinergic Antagonists; Dopamine Antagonists; Emergency Medical Technicia | 2016 |
FPIN's Clinical Inquiries. Treatment of motion sickness.
Topics: Antiemetics; Cholinergic Antagonists; Histamine Antagonists; Humans; Motion Sickness; Ondansetron; P | 2012 |
Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness.
Topics: Antiemetics; Humans; MEDLINE; Motion Sickness; Ondansetron; Postoperative Nausea and Vomiting | 1999 |
12 trials available for ondansetron and Air Sickness
| Article | Year |
|---|---|
Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea.
Topics: Adolescent; Adult; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Israel; Male; | 2009 |
Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; F | 2006 |
Meclizine in combination with ondansetron for prevention of postoperative nausea and vomiting in a high-risk population.
Topics: Adult; Drug Therapy, Combination; Elective Surgical Procedures; Female; Humans; Male; Meclizine; Mid | 2007 |
High dose ondansetron for reducing motion sickness in highly susceptible subjects.
Topics: Adolescent; Adult; Analysis of Variance; Antiemetics; Dimenhydrinate; Disease Susceptibility; Dose-R | 2007 |
Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Antiemetics; Craniotomy; Double-Blind Method; Female; Hum | 2007 |
Ondansetron 4 mg for the prevention of nausea and vomiting after minor laparoscopic gynaecological surgery.
Topics: Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Double-Blind Method; Female; Follow-Up Studi | 1994 |
Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Anesthesia, General; Antiemetics; | 1996 |
Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Age Factors; Aged; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemet | 1997 |
Anti-emetic drug effects on pilot performance: granisetron vs. ondansetron.
Topics: Administration, Oral; Adult; Aerospace Medicine; Affect; Antiemetics; Attention; Cross-Over Studies; | 1997 |
Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man.
Topics: Adolescent; Adult; Antiemetics; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; | 2000 |
The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
Topics: Adolescent; Adult; Antiemetics; Cross-Over Studies; Double-Blind Method; Electrodiagnosis; Female; G | 2000 |
The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.
Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Double-Blind Method; Electrooculography; E | 1989 |
1 other study available for ondansetron and Air Sickness
| Article | Year |
|---|---|
Thermoregulatory correlates of nausea in rats and musk shrews.
Topics: Animals; Body Temperature Regulation; Feeding Behavior; Hypothermia; Male; Motion Sickness; Nausea; | 2014 |